Jan Pachl

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 770 citations · Full text

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

Antoní Torres, Nanshan Zhong, Jan Pachl et al. · The Lancet Infectious Diseases · 2017 · 427 citations

Antibiotics, Ceftazidime-avibactam Versus Meropenem, Respiratory Infection +5

Intra-Arrest Transnasal Evaporative Cooling

Maaret Castrén, Per Nordberg, Leif Svensson et al. · Circulation · 2010 · 402 citations · Full text

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

John E. Mazuski, Leanne B. Gasink, J. Armstrong et al. · Clinical Infectious Diseases · 2016 · 376 citations · Full text

Ultrasound estimation of volume of pleural fluid in mechanically ventilated patients

Martin Balík, P Plasil, Petr Waldauf et al. · Intensive Care Medicine · 2006 · 344 citations · Full text

Medical Ultrasound, Medical Imaging, Thoracic Ultrasound +10